Portfolio company
Organovo
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops three-dimensional human tissues for drug discovery applications for pharmaceutical and biotechnology researchers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Hooke Bio
This company develops a microfluidic platform using three-dimensional human tissue models for preclinical drug testing for pharmaceutical and biotechnology organisations.
Cellink
This company develops 3D bioprinters and bioinks for researchers in academic, pharmaceutical and industrial laboratories to create human tissue models and organs.
Prometheus Life Technologies
The company produces human tissue organoids in microgravity for pharmaceutical researchers to improve drug development, testing and regenerative medicine.
Organo-ID
The company develops 3D organoid models and drug response tests for cancer patients and pharmaceutical researchers to improve personalised medicine and treatment efficacy.
insphero
The company develops three-dimensional microtissue models and cell culture tools for pharmaceutical and biotechnology researchers to test drug safety and efficacy.
iOrganBio
This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.
VISCIENT
This company develops novel therapies and drug discovery platforms using three-dimensional human tissue models to treat liver diseases for biopharmaceutical partners.
Organoids Hubrecht Instituut
This biotechnology company develops patient-derived 3D mini-organs from stem cells to provide drug discovery and preclinical testing services for pharmaceutical and biotechnology researchers.
